Fabio Trippa

ORCID: 0000-0003-0832-773X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Management of metastatic bone disease
  • Brain Metastases and Treatment
  • Glioma Diagnosis and Treatment
  • Radiopharmaceutical Chemistry and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Meningioma and schwannoma management
  • Endometrial and Cervical Cancer Treatments
  • Medical Imaging Techniques and Applications
  • Lung Cancer Diagnosis and Treatment
  • Ovarian cancer diagnosis and treatment
  • Head and Neck Cancer Studies
  • Spinal Fractures and Fixation Techniques
  • Breast Cancer Treatment Studies
  • Colorectal and Anal Carcinomas
  • MRI in cancer diagnosis
  • Lung Cancer Treatments and Mutations
  • Spine and Intervertebral Disc Pathology
  • Oral health in cancer treatment
  • Colorectal Cancer Surgical Treatments
  • Bone health and treatments
  • Head and Neck Surgical Oncology
  • Cancer Diagnosis and Treatment

Santa Maria Nuova Hospital
2016-2025

Azienda Ospedaliera S.Maria
2010-2024

Ospedale Santa Maria
2021-2023

LMU Klinikum
2019

Ludwig-Maximilians-Universität München
2019

Rabin Medical Center
2019

National Institute of Oncology
2017

Ottawa Regional Cancer Foundation
2017

Ottawa Hospital
2017

ASM Terni (Italy)
2015-2016

The aim of the present study is to evaluate impact metastases-directed stereotactic body radiotherapy in two groups oligometastatic prostate cancer (PC) patients: oligorecurrent PC and oligoprogressive castration-resistant (oligo-CRPC). Inclusion criteria multicentre retrospective analysis were: (1) PC, defined as presence 1–3 lesions (bone or nodes) detected with choline positron emission tomography CT plus bone scan following biochemical recurrence; (2) oligo-CRPC, metastases after a...

10.1038/bjc.2017.103 article EN cc-by-nc-sa British Journal of Cancer 2017-04-27

Diarrhoea is defined as the frequent passage of loose stools with urgency (or more than normal for individual). Objectively defined, it three unformed in 24 hours [1]. Often patient's definition diarrhoea varies and needs to be clarified by medical staff, through an adequate assessment.

10.1093/annonc/mdy145 article EN publisher-specific-oa Annals of Oncology 2018-04-19

Aims and background Few clinical data exist concerning normal brain tissue tolerance to re-irradiation. The present study evaluated long-term outcome of 22 recurrent glioblastoma patients re-irradiated with radiosurgery or fractionated stereotactic radiotherapy. Methods Twenty-two were treated (13, 59%) radiotherapy (9, 41%) for 24 lesions glioblastoma. male/female ratio was 14: 8, median age 55 years (range, 27–81), Karnofsky performance status 90 70–100). majority the cases (77%) in...

10.1177/030089161109700111 article EN Tumori Journal 2011-01-01

Abstract Background Moderate hypofractionated radiotherapy is a treatment option for the cure of localized prostate cancer (PCa) patients based on results randomized prospective trials, but there clinical concern about relatively short length follow-up, and real-world outcome toxicity cutting-edge techniques are lacking. The objective this study to present long-term large multicentric series. Materials methods We retrospectively evaluated 1325 PCa treated with daily volumetric image-guided...

10.1007/s11547-024-01782-2 article EN cc-by La radiologia medica 2024-02-19

Objective To evaluate both the patterns of prescription androgen deprivation therapy (ADT) in patients with prostate cancer (PCa) and adherence to European Association Urology (EAU) guidelines for ADT prescription. Methods The Choosing Treatment Prostate Cancer (CHOICE) study was an Italian multicentre cross‐sectional conducted between December 2010 January 2012. A total 1 386 patients, treated PCa (first or renewal ADT), were selected. With regard EAU on ADT, cohort categorized into...

10.1111/bju.13307 article EN BJU International 2015-09-02
Coming Soon ...